Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05659_nanopub.RAvmNcABVcxrUYqGA3DkV16XRq9EWcdTNvO_ktBtOIf38#assertion>. }
Showing items 1 to 15 of
15
with 100 items per page.
- drugbank:DB05659 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05659 label "faropenem medoxomil [drugbank:DB05659]" assertion.
- drugbank:DB05659 seeAlso DB05659 assertion.
- drugbank:DB05659 identifier "drugbank:DB05659" assertion.
- drugbank:DB05659 description "Faropenem medoxomil is an ester prodrug derivative of the beta-lactam antibiotic faropenem. The prodrug form of faropenem offers dramatically improved oral bioavailability and leads to higher systemic concentrations of the drug. Faropenem medoxomil is a broad-spectrum antibiotic that is highly resistant to beta-lactamase degradation. It is being developed jointly by Replidyne, Inc. and Forest Laboratories, Inc." assertion.
- drugbank:DB05659 title "faropenem medoxomil" assertion.
- drugbank:DB05659 bio2rdf_vocabulary:identifier "DB05659" assertion.
- drugbank:DB05659 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05659 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05659" assertion.
- drugbank:DB05659 bio2rdf_vocabulary:x-identifiers.org DB05659 assertion.
- drugbank:DB05659 drugbank_vocabulary:drugbank-id "DB05659" assertion.
- drugbank:DB05659 drugbank_vocabulary:x-cas cas:141702-36-5 assertion.
- drugbank:DB05659 drugbank_vocabulary:x-chemspider chemspider:5293428 assertion.
- drugbank:DB05659 drugbank_vocabulary:x-pubchemcompound pubchem.compound:6918218 assertion.
- drugbank:DB05659 drugbank_vocabulary:x-pubchemsubstance pubchem.substance:12014697 assertion.